Kenvue Inc. $KVUE Shares Acquired by Callahan Advisors LLC

Callahan Advisors LLC lifted its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 66.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 134,405 shares of the company’s stock after acquiring an additional 53,882 shares during the quarter. Callahan Advisors LLC’s holdings in Kenvue were worth $2,318,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Physician Wealth Advisors Inc. lifted its holdings in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after acquiring an additional 618 shares in the last quarter. Versor Investments LP lifted its holdings in shares of Kenvue by 2.8% during the 3rd quarter. Versor Investments LP now owns 26,016 shares of the company’s stock valued at $422,000 after acquiring an additional 716 shares in the last quarter. Philip James Wealth Mangement LLC lifted its holdings in shares of Kenvue by 5.5% during the 4th quarter. Philip James Wealth Mangement LLC now owns 13,888 shares of the company’s stock valued at $240,000 after acquiring an additional 726 shares in the last quarter. Phoenix Financial Ltd. lifted its holdings in shares of Kenvue by 5.4% during the 4th quarter. Phoenix Financial Ltd. now owns 15,195 shares of the company’s stock valued at $262,000 after acquiring an additional 783 shares in the last quarter. Finally, Titleist Asset Management LLC lifted its holdings in shares of Kenvue by 1.6% during the 3rd quarter. Titleist Asset Management LLC now owns 50,957 shares of the company’s stock valued at $827,000 after acquiring an additional 796 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

KVUE has been the topic of several recent research reports. Argus upgraded shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, May 8th. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. UBS Group reduced their target price on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Finally, Citigroup reduced their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat, Kenvue presently has a consensus rating of “Hold” and an average price target of $19.33.

Kenvue Stock Performance

Shares of KVUE stock opened at $17.33 on Thursday. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $24.35. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The firm has a market capitalization of $33.27 billion, a P/E ratio of 20.38, a P/E/G ratio of 1.30 and a beta of 0.55. The company’s fifty day moving average price is $17.42 and its two-hundred day moving average price is $17.39.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. During the same quarter in the previous year, the business posted $0.24 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. On average, research analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th will be issued a $0.2075 dividend. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. Kenvue’s payout ratio is currently 97.65%.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 1.59% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.